GW4064

99%

  • Product Code: 100758
  CAS:    278779-30-9
Molecular Weight: 542.84 g./mol Molecular Formula: C₂₈H₂₂Cl₃NO₄
EC Number: MDL Number: MFCD09971006
Melting Point: Boiling Point:
Density: Storage Condition: -20℃
Product Description: GW4064 is primarily used in research settings as a potent and selective agonist for the farnesoid X receptor (FXR), a nuclear receptor involved in regulating bile acid, lipid, and glucose metabolism. It is widely employed in studies investigating the role of FXR in metabolic disorders, such as non-alcoholic fatty liver disease (NAFLD), cholesterol homeostasis, and insulin resistance. Researchers utilize GW4064 to explore its potential therapeutic effects in modulating bile acid synthesis and improving metabolic parameters. Additionally, it serves as a valuable tool in understanding the molecular mechanisms of FXR signaling pathways and its impact on inflammation and fibrosis in liver-related diseases. Its application extends to drug discovery efforts aimed at developing FXR-targeted therapies for metabolic and hepatic conditions.
Product Specification:
Test Specification
Appearance White To Off-White Powder
Purity (%) 98.5-100
Infrared Spectrum Conforms To Structure
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.001 10-20 days £26.91
+
-
0.005 10-20 days £94.77
+
-
0.025 10-20 days £339.03
+
-
GW4064
GW4064 is primarily used in research settings as a potent and selective agonist for the farnesoid X receptor (FXR), a nuclear receptor involved in regulating bile acid, lipid, and glucose metabolism. It is widely employed in studies investigating the role of FXR in metabolic disorders, such as non-alcoholic fatty liver disease (NAFLD), cholesterol homeostasis, and insulin resistance. Researchers utilize GW4064 to explore its potential therapeutic effects in modulating bile acid synthesis and improving metabolic parameters. Additionally, it serves as a valuable tool in understanding the molecular mechanisms of FXR signaling pathways and its impact on inflammation and fibrosis in liver-related diseases. Its application extends to drug discovery efforts aimed at developing FXR-targeted therapies for metabolic and hepatic conditions.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: £0.00
£0.00 Total :